darapladib [Supplementary Concept]
a selective lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) inhibitor, on biomarkers of cardiovascular (CV) risk
Date introduced: May 21, 2008
MeSH Unique ID: C529040
Registry Number: UI1U1MYH09
Heading Mapped to:
Entry Terms:
- N-(2-(diethylamino)ethyl)-2-(2-((4-fluorobenzyl)sulfanyl)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopentapyrimidin-1-yl)-N-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)acetamide
- SB-480848
Pharmacologic Action: